Methotrexate is usually the first medicine given for rheumatoid arthritis, but certain side effects require immediate medical ...

Dear Doctors: My husband has been diagnosed with rheumatoid arthritis. One of his doctors says that when someone has RA, there’s a higher risk of cognitive impairment. He also said that some of the ...

Patients at risk of rheumatoid arthritis may wonder if there are lifestyle factors that play a role. What are some of the factors that you can discuss with them, and what can you recommend they do?

AN ANCIENT herbal remedy could reduce pain and inflammation and limit damage caused by arthritis, a new study showed. Its ...

Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...

A study looked at more than 23,600 Medicare beneficiaries with RA who had received a ≥30-day prescription of an opioid drug. Participants were grouped according to those who had been prescribed a ...

While effective in patients with painful rheumatoid arthritis, long-term use of opioids comes with risks, including dependency and adverse events. Could DMARDs lower the need for opioids?

Researchers conducted a systematic review and meta-analysis to determine the global prevalence of difficult-to-treat rheumatoid arthritis using the 2021 EULAR definition.

RA may increase the likelihood of experiencing diarrhea due to medication side effects, the presence of other autoimmune conditions, or complications like rheumatoid vasculitis and AA amyloidosis. Gut ...

Share on Pinterest Rejuvenating old blood by blocking inflammation could be the key to slowing aging, new research suggests. Design by Medical News Today; photography by Peter Dazeley/Getty Images The ...

Living with rheumatoid arthritis (RA) can significantly affect your mobility and quality of life. Many people turn to therapies and treatments, including soaking in a hot tub, to relieve symptoms.

After the FDA last week slapped safety warnings and use restrictions on AbbVie’s Rinvoq, Eli Lilly’s Olumiant and Pfizer’s Xeljanz, Wall Street has started rethinking its calculations for the JAK ...